Clin2
NCT06741800Possibly a fitNot yet recruiting

Dust mite allergy tablet and nose microbes study

Rhinitis, Allergic

Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.

This study looks at how a dust-mite allergy tablet (placed under the tongue) affects the tiny organisms in your nose. It may help doctors understand why some people respond better to the treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 65 years
Study type
Observational

Who can take part

  • You are between 18 and 65 years old
  • You have moderate to severe allergic rhinitis (not just mild symptoms)
  • You are allergic to dust mites (confirmed by a skin or blood test)
  • You are willing to provide samples (like a swab and fill out a questionnaire)
  • You do not have other nasal problems like a growth or tumor

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06741787Not yet recruiting
Spray under the tongue for dust mite allergies

This trial tests a spray placed under the tongue to treat allergic rhinitis caused by dust mites, pet dander, or mold. It looks at how the spray affects the bacteria in your nose and body.

Nanjing, Jiangsu
NCT04435990Recruiting· Phase 3
Allergy shots for dust mites in teens and adults

This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.

Santiago de Compostela, A Coruña
NCT05922176Recruiting
Microneedle patch testing to predict allergy treatment response

This study uses a small microneedle patch to collect skin-related samples to help predict how well allergy immunotherapy may work. It includes people with house dust mite allergy and also a healthy control group, so researchers can compare biomarker results.

Seoul
NCT07475715Not yet recruiting· Phase 2
Allergy drops for dust mite rhinitis

This trial tests allergy drops placed under the tongue to treat allergic rhinitis caused by house dust mites. It aims to see if the drops can safely reduce symptoms like sneezing and stuffy nose.

Hefei, Anhui
NCT06709092Recruiting
Testing Lupatadine for dust mite allergies

This study tests a new tablet (Lupatadine Fumarate) for people with nasal allergies caused by dust mites. It looks at how well the medicine works and what it does in the body.

Nanjing, Jiangsu
NCT07452380Recruiting
Dust mite allergy shot therapy for kids with rhinitis or asthma

This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.

Hangzhou, Zhejiang

Hear when a new Rhinitis, Allergic trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.